CASI Pharmaceuticals (CASIF) Net Income towards Common Stockholders (QoQ) (2022 - 2025)
CASI Pharmaceuticals (CASIF) Net Income towards Common Stockholders (QoQ) (2022 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
860,679.92 Bn |
860,679.89 Bn |
- |
| 2 |
Belite Bio |
55,284.00 Bn |
55,284.00 Bn |
- |
| 3 |
Quantum Biopharma |
16,206.94 Bn |
16,206.93 Bn |
- |
| 4 |
Legend Biotech |
3,318.00 Bn |
3,317.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,543.84 Bn |
1,543.84 Bn |
- |
| 6 |
Evaxion A |
1,449.11 Bn |
1,449.09 Bn |
- |
| 7 |
Psyence Biomedical |
216.99 Bn |
216.98 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
115.22 Bn |
107.97 Bn |
2.59 Bn |
| 9 |
Abivax |
90.58 Bn |
90.58 Bn |
- |
| 10 |
CASI Pharmaceuticals |
- |
- |
3.69 Mn |
| Date | Value |
|---|
| Dec 31, 2025 |
-668.78% |
| Sep 30, 2025 |
13.19% |
| Jun 30, 2025 |
-9.36% |
| Mar 31, 2025 |
23.28% |
| Dec 31, 2024 |
-52.32% |
| Sep 30, 2024 |
1.32% |
| Jun 30, 2024 |
4.92% |
| Mar 31, 2024 |
-159.85% |
| Dec 31, 2023 |
450.90% |
| Sep 30, 2023 |
51.27% |
| Jun 30, 2023 |
-30.67% |
| Mar 31, 2023 |
85.26% |
| Dec 31, 2022 |
-23.82% |
| Sep 30, 2022 |
-518.31% |
| Jun 30, 2022 |
8.14% |
